Leading Cardiac Diagnostics Innovator Zywie Announces Industry Partnership With MedAxiom
06 Agosto 2024 - 5:39AM
Business Wire
Zywie, a cardiovascular diagnostics pioneer specializing in
remote cardiac monitoring through wearable biosensor devices and
cloud-based data analytic solutions, announced today a partnership
with MedAxiom, the cardiovascular community’s premier source for
organizational performance solutions.
“We are proud to welcome Zywie to the MedAxiom community,” said
Joe Sasson, PhD, MedAxiom chief commercial officer and executive
vice president of ventures. “Remote rhythm monitoring is a crucial
tool for diagnosing cardiac arrhythmias. Zywie’s unique and
adaptable solutions offer an exciting opportunity to bring more
innovations to our members, provide education on the options and
strategies available to them, and advance our goal of transforming
cardiovascular care together.”
Zywie offers multiple types of monitors to fit the needs of
every physician and patient, including the ZywieNano™ patch, a
compact band-aid-like patch that continuously monitors the heart’s
electrical activity for up to 30 consecutive days. The data
collected by the ZywieNano™ patch is sent to Zywie’s cloud-based
platform, where it is analyzed by algorithms to provide insights
into a patient’s heart rhythm and potential cardiac conditions.
Zywie's unique ability to analyze patients' electrocardiograms in
real time allows clinicians to proactively address abnormal heart
rhythms before they worsen or become lethal.
“Zywie is excited to announce our partnership with MedAxiom, the
leader in cardiovascular organizational performance solutions,”
said Latha Ganeshan, Zywie CEO. “Zywie reaffirms its dedication to
advancing patient care through innovative cardiac diagnostics, and
this partnership enables us to collaborate closely on that mission
with MedAxiom's extensive network and expertise. Together with
MedAxiom, we are committed to delivering enhanced value to
patients, healthcare providers and the broader cardiovascular
community.”
Zywie’s platform has been shown to increase diagnostic yields
and actionable data for providers over standard 14-day monitors by
capturing the rhythms previously missed between days 15 to 30. The
higher diagnostic yield, or arrhythmia detection rate, increases
providers’ ability to accurately identify and diagnose
heart-related conditions.
About Zywie
Zywie is a full-suite, remote cardiac monitoring company
specializing in wearable biosensor devices and cloud-based data
analytic solutions. Zywie’s flagship product is the ZywieNano™
patch, a small band-aid-like patch that patients wear on their
chest to continuously monitor their heart’s electrical activity for
up to 30 days. The data collected by the ZywieNano™ patch is sent
to Zywie’s cloud-based platform, where it is analyzed by algorithms
to provide insights into a patient’s heart rhythm and potential
cardiac conditions. For additional information, visit
www.zywie.healthcare.
About MedAxiom
MedAxiom, an ACC Company, is the cardiovascular community’s
premier source for organizational performance solutions. MedAxiom
is transforming cardiovascular care by combining the knowledge and
power of hundreds of cardiovascular organization members, thousands
of administrators, clinicians and revenue cycle experts, and dozens
of industry partners. Through the delivery of proprietary tools,
smart data and proven strategies, MedAxiom helps cardiovascular
organizations achieve the Quadruple Aim of better outcomes, lower
costs, improved patient experience and improved clinician
experience. For additional information, visit www.MedAxiom.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806769009/en/
Laura Campbell CEO, Laura Campbell & Associates 615.579.6599
laura@laura-campbell.com